🍽️ Pediococcus pentosaceus

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of Pediococcus pentosaceus On Probiotics

Rank Probiotic Impact
species Escherichia coli Reduces

Bacteria Impacted by Pediococcus pentosaceus

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Campylobacteraceae family Decreases 👪 Source Study
Desulfovibrionaceae family Decreases 👪 Source Study
Enterobacteriaceae family Decreases 👪 Source Study
Eubacteriales Family XIII. Incertae Sedis family Decreases 👪 Source Study
Campylobacter genus Decreases 📓 Source Study Pathogen
Desulfovibrio genus Decreases 📓 Source Study
Escherichia genus Decreases 📓 Source Study
Mogibacterium genus Decreases 📓 Source Study BMI, fat percent,blood pressure
Shigella genus Decreases 📓 Source Study Pathogen
environmental samples no rank Decreases 👶 Source Study
unclassified Campylobacter no rank Decreases 👶 Source Study
unclassified Desulfovibrio no rank Decreases 👶 Source Study
unclassified Escherichia no rank Decreases 👶 Source Study
unclassified Mogibacterium no rank Decreases 👶 Source Study
unclassified Shigella no rank Decreases 👶 Source Study
Campylobacter armoricus species Decreases 👶 Source Study
Campylobacter avium species Decreases 👶 Source Study
Campylobacter blaseri species Decreases 👶 Source Study
Campylobacter canadensis species Decreases 👶 Source Study
Campylobacter coli species Decreases 👶 Source Study
Campylobacter concisus species Decreases 👶 Source Study
Campylobacter corcagiensis species Decreases 👶 Source Study
Campylobacter cuniculorum species Decreases 👶 Source Study
Campylobacter curvus species Decreases 👶 Source Study
Campylobacter faecalis species Decreases 👶 Source Study
Campylobacter fetus species Decreases 👶 Source Study
Campylobacter geochelonis species Decreases 👶 Source Study
Campylobacter gracilis species Decreases 👶 Source Study
Campylobacter helveticus species Decreases 👶 Source Study
Campylobacter hepaticus species Decreases 👶 Source Study
Campylobacter hominis species Decreases 👶 Source Study
Campylobacter hyointestinalis species Decreases 👶 Source Study
Campylobacter iguaniorum species Decreases 👶 Source Study
Campylobacter insulaenigrae species Decreases 👶 Source Study
Campylobacter jejuni species Decreases 👶 Source Study Gastroenteritis, Guillain-Barré syndrome
Campylobacter jejuni-like bacterium species Decreases 👶 Source Study
Campylobacter lanienae species Decreases 👶 Source Study
Campylobacter lari species Decreases 👶 Source Study
Campylobacter mucosalis species Decreases 👶 Source Study
Campylobacter novaezeelandiae species Decreases 👶 Source Study
Campylobacter ornithocola species Decreases 👶 Source Study
Campylobacter peloridis species Decreases 👶 Source Study
Campylobacter pinnipediorum species Decreases 👶 Source Study
Campylobacter rectus species Decreases 👶 Source Study
Campylobacter showae species Decreases 👶 Source Study
Campylobacter sputorum species Decreases 👶 Source Study
Campylobacter subantarcticus species Decreases 👶 Source Study
Campylobacter troglodytis species Decreases 👶 Source Study
Campylobacter upsaliensis species Decreases 👶 Source Study
Campylobacter ureolyticus species Decreases 👶 Source Study
Campylobacter volucris species Decreases 👶 Source Study
Campylobacter vulpis species Decreases 👶 Source Study
Candidatus Campylobacter infans species Decreases 👶 Source Study
Candidatus Desulfovibrio trichonymphae species Decreases 👶 Source Study
Desulfovibrio aminophilus species Decreases 👶 Source Study
Desulfovibrio biadhensis species Decreases 👶 Source Study
Desulfovibrio caledoniensis species Decreases 👶 Source Study
Desulfovibrio cuneatus species Decreases 👶 Source Study
Desulfovibrio desulfuricans species Decreases 👶 Source Study
Desulfovibrio fairfieldensis species Decreases 👶 Source Study Bacteremia
Desulfovibrio ferrophilus species Decreases 👶 Source Study
Desulfovibrio giganteus species Decreases 👶 Source Study
Desulfovibrio inopinatus species Decreases 👶 Source Study
Desulfovibrio intestinalis species Decreases 👶 Source Study
Desulfovibrio lacusfryxellense species Decreases 👶 Source Study
Desulfovibrio legallii species Decreases 👶 Source Study
Desulfovibrio litoralis species Decreases 👶 Source Study
Desulfovibrio longreachensis species Decreases 👶 Source Study
Desulfovibrio oryzae species Decreases 👶 Source Study
Desulfovibrio oviles species Decreases 👶 Source Study
Desulfovibrio oxyclinae species Decreases 👶 Source Study
Desulfovibrio piger species Decreases 👶 Source Study
Desulfovibrio psychrotolerans species Decreases 👶 Source Study
Desulfovibrio simplex species Decreases 👶 Source Study
Desulfovibrio subterraneus species Decreases 👶 Source Study
Desulfovibrio vulgaris species Decreases 👶 Source Study
Escherichia albertii species Decreases 👶 Source Study
Escherichia coli species Decreases 👶 Source Study Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome
Escherichia fergusonii species Decreases 👶 Source Study
Escherichia marmotae species Decreases 👶 Source Study
Mogibacterium diversum species Decreases 👶 Source Study
Mogibacterium neglectum species Decreases 👶 Source Study
Mogibacterium pumilum species Decreases 👶 Source Study
Mogibacterium timidum species Decreases 👶 Source Study
Mogibacterium vescum species Decreases 👶 Source Study
Shigella boydii species Decreases 👶 Source Study Dysentery
Shigella dysenteriae species Decreases 👶 Source Study Dysentery
Shigella flexneri species Decreases 👶 Source Study Dysentery, Shigellosis
Shigella sonnei species Decreases 👶 Source Study Dysentery

Impact of Pediococcus pentosaceus on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.5 0.5
Allergic Rhinitis (Hay Fever) 0.5 0.5
Allergies 0.4 0.3 0.33
Allergy to milk products 0.2 0.8 -3
Alzheimer's disease 1.8 0.5 2.6
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.3 0.4 2.25
Ankylosing spondylitis 2.1 0.3 6
Anorexia Nervosa 0.3 0.3
Antiphospholipid syndrome (APS) 0.2 0.2
Asthma 0.8 0.3 1.67
Atrial fibrillation 0.5 1 -1
Autism 2.1 1.4 0.5
Barrett esophagus cancer 0.8 -0.8
benign prostatic hyperplasia 1 1
Bipolar Disorder 1.8 1.8
Brain Trauma 0.8 0.8
Carcinoma 0.5 0.5
Celiac Disease 0.7 0.3 1.33
Chronic Fatigue Syndrome 0.2 0.2
Chronic Kidney Disease 1 1
Chronic Lyme 0.3 0.3
Chronic Urticaria (Hives) 0.7 0.7
Coagulation / Micro clot triggering bacteria 1.2 1.2
Colorectal Cancer 1.9 1.9
Constipation 1.3 1.3
COVID-19 2.2 2.2
Crohn's Disease 2.9 1 1.9
cystic fibrosis 0.7 0.7
deep vein thrombosis 1.2 1.2
Depression 2.1 1.2 0.75
Eczema 1.3 1.3
Endometriosis 1.9 1.9
Epilepsy 1.5 1.5
Functional constipation / chronic idiopathic constipation 1.4 1.4
gallstone disease (gsd) 0.5 0.5
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.5 0.5
Generalized anxiety disorder 1.2 1.2
giant cell arteritis 0.5 -0.5
Graves' disease 0.5 0.3 0.67
Halitosis 0.5 0.5
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.3 0.3
hyperglycemia 1 1
hypertension (High Blood Pressure 1.5 1.5
IgA nephropathy (IgAN) 0.3 0.3
Inflammatory Bowel Disease 1.7 1.7
Intracranial aneurysms 0.7 0.7
Irritable Bowel Syndrome 2.2 2.2
Liver Cirrhosis 1.8 0.5 2.6
Long COVID 1.5 1.3 0.15
Lung Cancer 1 1
Metabolic Syndrome 2.4 0.3 7
Mood Disorders 3.3 1.4 1.36
Multiple Sclerosis 0.8 0.8
myasthenia gravis 0.3 -0.3
Neuropathy (all types) 0.5 -0.5
neuropsychiatric disorders (PANDAS, PANS) 0.2 0.2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1.3 0.5 1.6
Obesity 2 0.5 3
obsessive-compulsive disorder 0.9 0.9
Osteoarthritis 0.5 0.5
Osteoporosis 1 1
Parkinson's Disease 0.9 0.5 0.8
Polycystic ovary syndrome 1.3 1.3
Postural orthostatic tachycardia syndrome 0.3 0.3
Psoriasis 0.2 0.2
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 2 2
Schizophrenia 1 0.3 2.33
Sjögren syndrome 1 1
Sleep Apnea 0.8 0.8
Small Intestinal Bacterial Overgrowth (SIBO) 0.9 0.9
Stress / posttraumatic stress disorder 0.9 0.9
Systemic Lupus Erythematosus 1.8 0.5 2.6
Type 1 Diabetes 0.5 0.5
Type 2 Diabetes 2.4 0.2 11
Ulcerative colitis 1.4 0.5 1.8
Unhealthy Ageing 1.3 1.3

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)